Fujifilm inks $3B Regeneron deal ahead of Holly Springs plant opening

Fujifilm inks $3B Regeneron deal ahead of Holly Springs plant opening

Fujifilm Diosynth has landed a $3 billion, 10-year manufacturing deal with Regeneron at its Holly Springs facility, which is set to open later this year. It’s the third major customer after Johnson & Johnson and TG Therapeutics. The site is the Triangle’s largest life sciences project.

FUJIFILM Diosynth Biotechnologies and Regeneron Sign 10-year, $3+ Billion U.S. Manufacturing Deal

FUJIFILM Diosynth Biotechnologies signed a 10-year manufacturing supply agreement, valued at over $3 billion, with Regeneron Pharmaceuticals to provide U.S.-based production of its biologic medicines. FUJIFILM will provide U.S.-based manufacturing for Regeneron over the 10-year period through current and planned expansions at its new large-scale biopharmaceutical manufacturing facility in Holly Springs, NC, when the site begins operations later …